211 related articles for article (PubMed ID: 12499378)
1. Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.
Fan C; Liu M; Wang Q
J Biol Chem; 2003 Mar; 278(10):8780-5. PubMed ID: 12499378
[TBL] [Abstract][Full Text] [Related]
2. Functional role of transcriptional factor TBX5 in pre-mRNA splicing and Holt-Oram syndrome via association with SC35.
Fan C; Chen Q; Wang QK
J Biol Chem; 2009 Sep; 284(38):25653-63. PubMed ID: 19648116
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome.
Ghosh TK; Packham EA; Bonser AJ; Robinson TE; Cross SJ; Brook JD
Hum Mol Genet; 2001 Sep; 10(18):1983-94. PubMed ID: 11555635
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations.
Jhang WK; Lee BH; Kim GH; Lee JO; Yoo HW
Cardiol Young; 2015 Aug; 25(6):1093-8. PubMed ID: 25216260
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of TBX5-DNA recognition: the T-box domain in its DNA-bound and -unbound form.
Stirnimann CU; Ptchelkine D; Grimm C; Müller CW
J Mol Biol; 2010 Jul; 400(1):71-81. PubMed ID: 20450920
[TBL] [Abstract][Full Text] [Related]
6. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.
Hiroi Y; Kudoh S; Monzen K; Ikeda Y; Yazaki Y; Nagai R; Komuro I
Nat Genet; 2001 Jul; 28(3):276-80. PubMed ID: 11431700
[TBL] [Abstract][Full Text] [Related]
7. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed.
Mori AD; Bruneau BG
Curr Opin Cardiol; 2004 May; 19(3):211-5. PubMed ID: 15096952
[TBL] [Abstract][Full Text] [Related]
8. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome.
Basson CT; Bachinsky DR; Lin RC; Levi T; Elkins JA; Soults J; Grayzel D; Kroumpouzou E; Traill TA; Leblanc-Straceski J; Renault B; Kucherlapati R; Seidman JG; Seidman CE
Nat Genet; 1997 Jan; 15(1):30-5. PubMed ID: 8988165
[TBL] [Abstract][Full Text] [Related]
9. TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome.
Guo DF; Li RG; Yuan F; Shi HY; Hou XM; Qu XK; Xu YJ; Zhang M; Liu X; Jiang JQ; Yang YQ; Qiu XB
Mol Med Rep; 2016 May; 13(5):4349-56. PubMed ID: 27035640
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.
Varela D; Varela T; Conceição N; Ferreira Â; Marques N; Silva AP; Azevedo P; Pereira S; Camacho A; de Jesus I; Cancela ML
Mol Genet Genomics; 2021 Jul; 296(4):809-821. PubMed ID: 33866394
[TBL] [Abstract][Full Text] [Related]
11. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.
Murakami M; Nakagawa M; Olson EN; Nakagawa O
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18034-9. PubMed ID: 16332960
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications.
Al-Qattan MM; Abou Al-Shaar H
Gene; 2015 Apr; 560(2):129-36. PubMed ID: 25680289
[TBL] [Abstract][Full Text] [Related]
13. Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
van Ouwerkerk AF; Bosada FM; van Duijvenboden K; Houweling AC; Scholman KT; Wakker V; Allaart CP; Uhm JS; Mathijssen IB; Baartscheer T; Postma AV; Barnett P; Verkerk AO; Boukens BJ; Christoffels VM
Circulation; 2022 Feb; 145(8):606-619. PubMed ID: 35113653
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the novel TBX5 c.1333delC mutation resulting in an extended TBX5 protein.
Böhm J; Heinritz W; Craig A; Vujic M; Ekman-Joelsson BM; Kohlhase J; Froster U
BMC Med Genet; 2008 Oct; 9():88. PubMed ID: 18828908
[TBL] [Abstract][Full Text] [Related]
15. Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.
Brassington AM; Sung SS; Toydemir RM; Le T; Roeder AD; Rutherford AE; Whitby FG; Jorde LB; Bamshad MJ
Am J Hum Genet; 2003 Jul; 73(1):74-85. PubMed ID: 12789647
[TBL] [Abstract][Full Text] [Related]
16. KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.
Darwich R; Li W; Yamak A; Komati H; Andelfinger G; Sun K; Nemer M
Hum Mol Genet; 2017 Mar; 26(5):942-954. PubMed ID: 28164238
[TBL] [Abstract][Full Text] [Related]
17. Novel TBX5 mutations in patients with Holt-Oram syndrome.
Debeer P; Race V; Gewillig M; Devriendt K; Frijns JP
Clin Orthop Relat Res; 2007 Sep; 462():20-6. PubMed ID: 17534187
[TBL] [Abstract][Full Text] [Related]
18. TBX5, a gene mutated in Holt-Oram syndrome, is regulated through a GC box and T-box binding elements (TBEs).
Sun G; Lewis LE; Huang X; Nguyen Q; Price C; Huang T
J Cell Biochem; 2004 May; 92(1):189-99. PubMed ID: 15095414
[TBL] [Abstract][Full Text] [Related]
19. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation.
Postma AV; van de Meerakker JB; Mathijssen IB; Barnett P; Christoffels VM; Ilgun A; Lam J; Wilde AA; Lekanne Deprez RH; Moorman AF
Circ Res; 2008 Jun; 102(11):1433-42. PubMed ID: 18451335
[TBL] [Abstract][Full Text] [Related]
20. TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts.
Reamon-Buettner SM; Borlak J
Hum Mutat; 2004 Jul; 24(1):104. PubMed ID: 15221798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
